MedPath

ADAM OLSON

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 2:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 2
1 (50.0%)

Bacterial Decolonization Plus Intraoperative Angiography for Soft Tissue Sarcomas Receiving Preoperative Radiotherapy (CONCERTO)

Phase 2
Not yet recruiting
Conditions
Sarcoma,Soft Tissue
Interventions
Drug: 2% intranasal mupirocin ointment
First Posted Date
2024-12-02
Last Posted Date
2025-04-24
Lead Sponsor
Adam Olson
Target Recruit Count
31
Registration Number
NCT06712433
Locations
🇺🇸

UPMC Hillman Cancer Centers, Pittsburgh, Pennsylvania, United States

Hypofractionated SBRT For Prostate Cancer

Not Applicable
Completed
Conditions
Prostate Cancer
First Posted Date
2009-09-16
Last Posted Date
2024-05-02
Lead Sponsor
Adam Olson
Target Recruit Count
163
Registration Number
NCT00977860
Locations
🇺🇸

UPMC Hillman Cancer Center - Shadyside Radiation Oncology, Pittsburgh, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.